GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visiomed Group (XPAR:ALVMG) » Definitions » YoY EBITDA Growth

Visiomed Group (XPAR:ALVMG) YoY EBITDA Growth : 316.67% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Visiomed Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Visiomed Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 316.67%.

Visiomed Group's EBITDA per Share for the six months ended in Dec. 2023 was €0.01.


Visiomed Group YoY EBITDA Growth Historical Data

The historical data trend for Visiomed Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visiomed Group YoY EBITDA Growth Chart

Visiomed Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.97 87.32 88.83 60.00 300.00

Visiomed Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.60 102.90 -300.00 50.00 316.67

Visiomed Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Visiomed Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.016--0.008)/ | -0.008 |
=300.00 %

Visiomed Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.013--0.006)/ | -0.006 |
=316.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visiomed Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Visiomed Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Visiomed Group (XPAR:ALVMG) Business Description

Traded in Other Exchanges
Address
8, Avenue Kléber, Paris, FRA, 75116
Visiomed Group is engaged in the development, designing, and marketing of medical products. The product portfolio includes various thermometers, natural mud, cold spray, connected activity bracelets, connected scales, inhalers, humidifiers, baby flies, natural wax, comfort foam, antibacterial solutions, baby nutrition, baby accessories, among others.

Visiomed Group (XPAR:ALVMG) Headlines

No Headlines